Editorial · 30 Nov 2021
Conference abstractPublished 31 Dec 2020
Update on gene therapy and other treatment modalities for adenosine deaminase deficiency
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Adenosine deaminase (ADA) deficiency is one of the primary immunodeficiency diseases, that affects the immune system through accumulated metabolites of purine metabolism. It is an autosomal-recessive disorder with an estimated incidence around 0.5 per 100,000 live births. Patients with severe form usually present in infancy where the accumulation of the toxic metabolites; deoxyadenosine and deoxyadenosine triphosphate (dAXP), causing defective differentiation and function of immune cells; T, B, and natural killer (NK) leading to severe combined immunodeficiny.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Next Generation Sequencing & Applications.
Editorial · 30 Nov 2021
Bioinformatics Tools Resource in Evaluating Biomolecule
Perspective · 30 Nov 2021
A Biomarker Can Form Molecule Indicating the Lifestyles
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Next Generation Sequencing & Applications
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Dr. Daifulah ALZahrani”